HOME >> BIOLOGY >> NEWS
Vaccine hope for sufferers of potentially fatal stomach bug

Scientists at The University of Nottingham have been awarded over 366,000 to help unravel the mystery of a stomach bug which causes gastric ulcers and cancer. Their research could lead to the development of a vaccine for those most at risk.

The bacterium, Helicobacter pylori (Hp), lives in the stomachs of approximately half the worlds population. Dr Karen Robinson, a lecturer at the Centre of Biomolecular Sciences and co-researcher John Atherton, Professor of Gastroenterology and Head of the Wolfson Digestive Diseases Centre, lead a team of scientists that have spent the last three years trying to discover why most people are immune to the bug while it can cause potentially fatal disease in some people.

Dr Robinson says this new funding, from the Medical Research Council, will allow them to address one of the most important questions in Helicobacter research why some infected individuals develop ulcers or gastric cancer whilst others remain asymptomatic. My interest is in the immune response and how this dictates whether or not an infected person goes on to develop disease.

In recent studies the team has shown that the bacteria induce changes to the immune system which calm the inflammation down. However, sometimes this relationship goes wrong. Their experiments showed that people with ulcers often have a suppressed protective response, leading to the development of severe inflammation and ulceration of the stomach lining.

If we become infected with Hp it generally happens in childhood. The bacteria can remain undetected in the stomach for life. However, in some people it causes inflammation which leads to gastric ulcers or cancer in later years. Scientists at The University of Nottingham believe the Hp manipulates the immune system and patients arent aware of a problem until the disease has become so advanced they need surgery or chemotherapy.

The occurrence of the disease is currently thought to be due to
'"/>

Contact: Karen Robinson
44-011-582-31094
University of Nottingham
26-Apr-2007


Page: 1 2

Related biology news :

1. Vaccine trials inject hope into koalas future
2. Vaccine hope for malaria
3. Vaccine prevents prion disease in mice
4. Vaccine to cope with viral diversity in HIV
5. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
6. U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication
7. Vaccine-producing plant-factories
8. HPV Vaccine: Whats next
9. Vaccine shown effective against chancroid
10. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
11. Vaccine provides 100 percent protection against avian flu virus in animal study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2019)... ... March 08, 2019 , ... On International Women’s Day, the ... focused on women in the field. The Women in Cancer Immunotherapy Network ... and empower emerging female leaders in the cancer immunotherapy field. , Scheduled for ...
(Date:3/1/2019)... ... 28, 2019 , ... Teresa Krabbe, Ph.D., a student in the working group ... has been awarded an xCELLigence Research Grant for her proposal to develop adoptive T ... , Oncolytic viruses represent an exciting new aspect in the evolving field of cancer ...
(Date:2/22/2019)... ... February 20, 2019 , ... As ... medicine, the traditional line between engineering and medical science grows ever thinner. As ... the medical device industry is making medical practice easier for doctors, more effective ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... March 14, 2019 , ... ... in Oklahoma City, OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma ... Center as the fifth institution in Oklahoma to receive this prestigious endorsement. ...
(Date:3/14/2019)... ... March 13, 2019 , ... The ... Biotechnology Conference , taking place in Brussels, Belgium on 25–26 September 2019. This ... operational solutions, and innovative approaches. , “Biopharmaceuticals have become a main pillar ...
(Date:3/11/2019)... ... , ... USDM Life Sciences and Generis have partnered ... GxP compliance for the life sciences industry. USDM Cloud Assurance delivers a ... for Generis’ flagship product, CARA. , Presentation One:, What: Cloud ...
(Date:3/4/2019)... TORONTO (PRWEB) , ... March 04, 2019 , ... Stay on top of current hot ... industries. Access to all webinars is free, so be sure to register today to save ... http://www.xtalks.com to see our upcoming webinars: , CLINICAL TRIALS, , ...
Breaking Biology Technology:
Cached News: